HER2 breast cancer cells adopt a strategy to resist clearance by redirected lymphocytes; findings evidence that the disruption of interferon-gamma signaling confers resistance to these immunotherapies.
from Medindia Health News https://ift.tt/3snTQLH
No comments:
Post a Comment